Thus, in addition to the negative impact of TET2 decreased expression and its association with PAH [70], TET activity can negatively influence the function of several organs and systems in which functional irregularities are observed among COVID-19 patients. The gene discussed is TET2; the disease is pulmonary arterial hypertension.